28 February 2013
The final conference of NANOGENOTOX took place on Friday 22 February 2013 and was hosted by the French Ministry of Social Affairs and purchase cialis online without prescription Health, in Paris, France. It gathered around 200 participants from all over Europe and viagra online beyond, including partners of the Joint Action.
The results of each WP were presented and get cialis online discussed in the morning sessions. In the afternoon, a presentation summarizing the considerations to achieve a robust method for testing the genotoxicity of MNs was made, followed by discussions with the audience (see agenda). Particular efforts were made during the panel discussion and viagra seizures in the conclusions and cialis for sale perspectives by policy makers to examine how this method can be taken up and cheap canadian viagra followed upon within REACH or other regulatory mechanisms.
As policy makers, the OECD WPMN and the EC DG SANCO representatives confirmed that the results and free trial of viagra lessons coming out from NANOGENOTOX can be built upon for risk assessment and viagra no prescription risk management purposes. Existing frameworks and real viagra guidelines are applicable for nanomaterials but some particular test guidelines have to be examined closely and overnight canadian viagra may need to be updated or replaced. The concerns identified in the NANOGENOTOX findings are shared by the EC Scientific Committee on Consumer Safety (SCCS).
To view the presentations from this meeting, click on the following pictures.